Form 4 for BBIO BridgeBio Pharma, Inc.
Accepted 2025-11-18 00:00:00 ET · period of report 2025-11-16 · accession 0001470831-25-000353 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-11-18 | 2025-11-16 | BBIO | Kumar Neil | CEO, Dir | M - OptEx | — | +64.7K | 276.2K | +31% | — |
| D | 2025-11-18 | 2025-11-16 | BBIO | Kumar Neil | CEO, Dir | F - Tax | $66.39 | -32.9K | 254.9K | -11% | -$2.18M |
| DM | 2025-11-18 | 2025-11-16 | BBIO | Kumar Neil | CEO, Dir | M - OptEx | $0.00 | -64.7K | 176.4K | -27% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-16 | M | A | 33,544 | — | 256,634 | D | — | — | (F1) Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. |
| 2 | Common | Common Stock | 2025-11-16 | F | D | 32,855 | $66.39 | 254,932 | D | — | — | (F2) Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 64,697 shares of Common Stock underlying the Reporting Person's RSUs. |
| 3 | Common | Common Stock | 2025-11-16 | M | A | 11,554 | — | 287,787 | D | — | — | (F1) Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. |
| 4 | Common | Common Stock | 2025-11-16 | M | A | 19,599 | — | 276,233 | D | — | — | (F1) Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. |
| 5 | Derivative | Restricted Stock Units | 2025-11-16 | M | D | 33,544 | $0.00 | 167,720 | D | — · — to — | 33,544 Common Stock | (F1) Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. (F4) The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2023. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date. |
| 6 | Derivative | Restricted Stock Units | 2025-11-16 | M | D | 11,554 | $0.00 | 150,199 | D | — · — to — | 11,554 Common Stock | (F1) Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. (F6) The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2025. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date. |
| 7 | Derivative | Restricted Stock Units | 2025-11-16 | M | D | 19,599 | $0.00 | 176,394 | D | — · — to — | 19,599 Common Stock | (F1) Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. (F5) The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2024. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date. |